🔗 Permalink

Inventor profile of:

Mark R. Brann

City:

Rye, New Hampshire

Country:

United States

Published Applications:

Last publication date:

2024-03-21

Top Assignees for applications by Mark R. Brann

The entities that hold a legal rights for patent applications filed by inventor Brann Mark R.:

Acadia Pharmaceuticals, Inc. 16 San Diego, CA United States

Recent patent applications by Brann Mark R.

Mark R. Brann from Rye, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-21

US20240091212A1

Human necessities

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

#2 | 2022-08-04

US20220241265A1

Human necessities

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

#3 | 2020-10-15

US20200323836A1

Human necessities

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

#4 | 2019-01-31

US20190030015A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#5 | 2017-07-27

US20170209424A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#6 | 2016-09-01

US20160250200A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#7 | 2015-07-23

US20150202194A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#8 | 2014-05-22

US20140140982A1

Chemistry; metallurgy

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#9 | 2013-05-30

US20130137727A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#10 | 2012-11-01

US20120277221A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#11 | 2011-10-20

US20110257229A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#12 | 2010-09-09

US20100227886A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#13 | 2010-09-09

US20100227885A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#14 | 2009-10-13

US10759561

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#15 | 2009-01-15

US20090018119A1

Human necessities

USE OF N-DESMETHYLCLOZAPINE TO TREAT HUMAN NEUROPSYCHIATRIC DISEASE

#16 | 2008-02-28

US20080051429A1

Human necessities

USE OF 4-AMINO-PIPERIDINES FOR TREATING SLEEP DISORDERS

#17 | 2007-11-29

US20070275957A1

Human necessities

USE OF N-DESMETHYLCLOZAPINE TO TREAT HUMAN NEUROPSYCHIATRIC DISEASE

#18 | 2006-11-23

US20060264466A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#19 | 2006-11-23

US20060264465A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#20 | 2006-09-07

US20060199842A1

Human necessities

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

InventorID:

770126 ⎘